JPRN-UMIN000021899已完成未知
ong-term efficacy and safety of istradefylline for the treatment of advanced Parkinson's disease - Long-term efficacy and safety of istradefylline for the treatment of advanced Parkinson's disease
Abe Neurology Clinic0 个研究点目标入组 45 人开始时间: 2016年4月13日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients with moderate or severe liver disorder or taking medications that strongly inhibit CYP3A4 2.Patients who are nursing or pregnant or might be pregnant 3.Patients in whom efficacy data were not collected at 6 and 12 months after oral treatment with istradefylline
研究者
相似试验
已完成
不适用
Clinical efficacy and safety of istradefylline in the treatment of advanced Parkinson's disease: a retrospective studys diseaseParkinson's diseaseJPRN-UMIN000020562Himeji Central Hospital50
已完成
不适用
Intervention study of Istradefylline for the Treatment of Abnormal Posture in Patients with Parkinson's DiseaseParkinson's diseaseJPRN-UMIN000026492Osaka Red Cross Hospital31
已完成
不适用
Intervention Study of Istradefylline for the Treatment of Gait Disorders in Patients with Parkinson's Disease.Parkinson's diseaseJPRN-UMIN000020288Juntendo University Shizuoka Hospital30
已完成
不适用
Intervention Study for the effect of Istradefylline on onset of Dyskinesia in Patients with Parkinson's Disease.s diseaseParkinson's diseaseJPRN-UMIN000024536Fukuoka University214
已完成
不适用
ODYSSEI StudyParkinson's diseaseJPRN-jRCTs071180014Tsuboi Yoshio280